Rachel Kisnonsky, PA
Physician Assistant · Grand Rapids, MINPI 1407609589
Payments from drug & device makers
Across 140 payments — averaging $27.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$296
- Merck$247
- Astellas Pharma US Inc$240
- Novartis$239
- AstraZeneca$230
- Daiichi Sankyo Inc.$207
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,05980%
- Education$77820%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead(2 entities) | 8 | $296 |
| Merck | 9 | $247 |
| Astellas Pharma US Inc | 4 | $240 |
| Novartis | 13 | $239 |
| AstraZeneca | 8 | $230 |
| Daiichi Sankyo Inc. | 10 | $207 |
| Seagen Inc. | 2 | $184 |
| Sanofi | 4 | $177 |
| Ipsen Biopharmaceuticals, Inc | 4 | $158 |
| Incyte Corporation | 4 | $155 |
| Pfizer | 9 | $134 |
| Genentech USA, Inc. | 6 | $133 |
| Johnson & Johnson | 6 | $129 |
| Beone Medicines USA, Inc. | 4 | $110 |
| Array Biopharma Inc | 6 | $106 |
| GSK | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Eisai Inc. | 3 | $82 |
| E.r. Squibb & Sons, L.L.C. | 3 | $79 |
| Geron Corporation | 2 | $75 |
| Sobi, Inc | 3 | $64 |
| Lilly USA, LLC | 3 | $60 |
| Tersera Therapeutics LLC | 2 | $49 |
| Servier Pharmaceuticals LLC | 2 | $48 |
| Deciphera Pharmaceuticals Inc. | 2 | $39 |
| Caris MPI, Inc. | 1 | $39 |
| Bayer | 1 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| ADC Therapeutics America, Inc. | 1 | $34 |
| Stemline Therapeutics Inc. | 1 | $33 |
| EMD Serono, Inc. | 1 | $31 |
| Tempus AI, Inc | 1 | $31 |
| Pharmacosmos Therapeutics Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Invivyd Inc | 1 | $14 |
How this compares
$3,837 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Melissa JosephGrand Rapids$82K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.